Who to call at Telomir Pharmaceuticals, and when
Fundz watches for the moments Telomir Pharmaceuticals starts buying, and tells you who to reach.
- An alert the day Telomir Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Telomir Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Telomir Pharmaceuticals. With Fundz connected, it knows.
Contract Type
clinical_trial_agreement
Description
Telomir Pharmaceuticals, Inc. has announced the selection of Linical, a global contract research organization, to assist in its Phase 1/2 clinical trial of Telomir-Zn for advanced triple-negative breast cancer. A Master Services Agreement and clinical trial Work Order have been executed to advance the study toward clinical initiation in the first quarter of 2027. Linical brings over two decades of oncology expertise to support this critical development phase.
Quick answer
Telomir Pharmaceuticals Engages Linical for Clinical Trial Support (November 18, 2026). Telomir Pharmaceuticals is based in Miami, Florida, United States.
- What agreement did Telomir Pharmaceuticals announce on November 18, 2026?
- Telomir Pharmaceuticals, Inc. has announced the selection of Linical, a global contract research organization, to assist in its Phase 1/2 clinical trial of Telomir-Zn for advanced triple-negative breast cancer. A Master Services Agreement and clinical trial Work Order have been executed to advance the study toward clinical initiation in the first quarter of 2027.
- What does Telomir Pharmaceuticals do?
- Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of Telomir-1, the first novel small molecule to lengthen the DNA’s protective telomere caps...
- Where is Telomir Pharmaceuticals based?
- Telomir Pharmaceuticals is based in Miami, Florida, United States.
- Which similar companies announced agreements around the same time?
- AstraZeneca Pharma India (November 17, 2026), Pfizer (November 14, 2026), Sino Biopharmaceutical (November 13, 2026) and Edesa Biotech (November 9, 2026) also announced agreements within 45 days of Telomir Pharmaceuticals.
Source: Fundz verified event record.
Other recent agreements in Pharmaceutical and Biopharma
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- AstraZeneca Pharma India Forms Partnership with Strand Life Sciences for Healthcare Collaboration. (November 17, 2026)
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- Edesa Biotech Enters Collaboration and License Agreement with Kyorin Pharmaceutical (November 9, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Celltrion Secures Exclusive Supply Agreement for Omlyclo and Aptozma with U.S. Healthcare Company to Expand Market Access. (October 26, 2026)
Related People
Telomir Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.